Caris Life Sciences, Inc. (CAI) Financial Analysis & Valuation | Quarter Chart
Caris Life Sciences, Inc. (CAI)
CAIPrice: $18.32
Fair Value: 🔒
🔒score
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's mol... more
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling ... more
Description
Shares
| Market Cap | $5.18B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | US | CEO | David Dean Halbert |
| IPO Date | 2025-06-18 | CAGR | 0.14% |
| Employees | 1,769 | Website | www.carislifesciences.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.27% | Total Yield | 0.27% |
CAI chart loading...
Fundamentals
Technicals
| Enterprise Value | $5.02B | P/E Ratio | -100.77 |
| Forward P/E | 50.09 | PEG Ratio | — |
| P/S Ratio | 6.74 | P/B Ratio | 10.29 |
| P/CF Ratio | 41.47 | P/FCF Ratio | 49.52 |
| EPS | $-0.18 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 125.43% | Gross Margin | 0.69% |
| Operating Margin | 0.16% | Profit Margin | 0.04% |
| ROE | 0.06% | ROA | 0.03% |
| ROCE | 0.14% | Current Ratio | 7.05 |
| Quick Ratio | 7.05 | Cash Ratio | 5.71 |
| Debt/Equity | 0 | Interest Coverage | 2.54 |
| Altman Z Score | 4.32 | Piotroski Score | 8 |